![Frontiers | Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect Frontiers | Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect](https://www.frontiersin.org/files/Articles/643824/fmolb-08-643824-HTML/image_m/fmolb-08-643824-t001.jpg)
Frontiers | Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect
![Levo-tetrahydropalmatine attenuates oxaliplatin-induced mechanical hyperalgesia in mice | Scientific Reports Levo-tetrahydropalmatine attenuates oxaliplatin-induced mechanical hyperalgesia in mice | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep03905/MediaObjects/41598_2014_Article_BFsrep03905_Fig1_HTML.jpg)
Levo-tetrahydropalmatine attenuates oxaliplatin-induced mechanical hyperalgesia in mice | Scientific Reports
![Neurotoxic Side Effects Early in the Oxaliplatin Treatment Period in Patients With Colorectal Cancer. | Semantic Scholar Neurotoxic Side Effects Early in the Oxaliplatin Treatment Period in Patients With Colorectal Cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fe7d59ae3376013046f42f2c8ccb1d61bfa083ea/3-Figure1-1.png)
Neurotoxic Side Effects Early in the Oxaliplatin Treatment Period in Patients With Colorectal Cancer. | Semantic Scholar
![Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial - eClinicalMedicine Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3471783e-d95d-428d-96a0-b85ce4216aa2/gr1_lrg.jpg)
Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial - eClinicalMedicine
![Genome-wide single-nucleotide resolution of oxaliplatin–DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines - Journal of Biological Chemistry Genome-wide single-nucleotide resolution of oxaliplatin–DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/28cf8d94-c076-4bfd-b762-b3534935c2da/gr1_lrg.jpg)
Genome-wide single-nucleotide resolution of oxaliplatin–DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines - Journal of Biological Chemistry
![Effect of regulatory T-cell repletion on oxaliplatin-induced mechanical... | Download Scientific Diagram Effect of regulatory T-cell repletion on oxaliplatin-induced mechanical... | Download Scientific Diagram](https://www.researchgate.net/publication/312956439/figure/fig4/AS:455125434146821@1485521767595/Effect-of-regulatory-T-cell-repletion-on-oxaliplatin-induced-mechanical-allodynia-in.png)
Effect of regulatory T-cell repletion on oxaliplatin-induced mechanical... | Download Scientific Diagram
![Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents - ScienceDirect Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804911006095-gr1.jpg)
Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents - ScienceDirect
![Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis](https://f6publishing.blob.core.windows.net/6bfe3ee9-f382-4b63-9adb-86f4ca6468d9/WJMA-8-27-g004.png)
Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis
![Neurotoxic Side Effects Early in the Oxaliplatin Treatment Period in Patients With Colorectal Cancer. | Semantic Scholar Neurotoxic Side Effects Early in the Oxaliplatin Treatment Period in Patients With Colorectal Cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fe7d59ae3376013046f42f2c8ccb1d61bfa083ea/2-Table1-1.png)
Neurotoxic Side Effects Early in the Oxaliplatin Treatment Period in Patients With Colorectal Cancer. | Semantic Scholar
![Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity | SpringerLink Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs43440-020-00106-1/MediaObjects/43440_2020_106_Fig2_HTML.png)
Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity | SpringerLink
![Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis](https://f6publishing.blob.core.windows.net/articleqrcode/10-13105-wjma-v8-i1-27-qc-html.png)
Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis
Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum Accumulation | PLOS ONE
![Reintroduction of Oxaliplatin: A Viable Approach to the Long-Term Management of Metastatic Colorectal Cancer | Semantic Scholar Reintroduction of Oxaliplatin: A Viable Approach to the Long-Term Management of Metastatic Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ea53111994c9e779e57a100ac353f491e6f4a240/6-Figure1-1.png)
Reintroduction of Oxaliplatin: A Viable Approach to the Long-Term Management of Metastatic Colorectal Cancer | Semantic Scholar
![Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02141-z/MediaObjects/13046_2021_2141_Fig1_HTML.png)
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text
![Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities - Cancer Treatment Reviews Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8503bdf9-68e2-44ed-bc2e-c29123bd06ef/gr1.jpg)
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities - Cancer Treatment Reviews
![Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents - ScienceDirect Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804911006095-gr3.jpg)